From another investigation, TWIST1 is overexpressed in approximately 40% of NSCLC cases and connected with a more aggressive tumor phenotype, an increased risk of metastasis, and poorer patient prognosis [300]. Here, TWIST1 is linked to non-small cell lung carcinoma.